May CPI and Housing...
Health Care: Drugs
Idenix Pharmaceuticals Inc. (IDIX: NASDAQ)
$5.29 -0.10 | -1.86%
06/19/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 230.83M | 118.27M | 46.12M | 46.52M |
| Receivables | 1.20M | 1.16M | 840.00K | 1.05M |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 3.67M | 4.00M | 2.12M | 1.50M |
| Total Current Assets | 237.79M | 123.84M | 49.49M | 51.58M |
| Property, Plant & Equipment, Gross | 22.13M | 21.57M | 25.13M | 27.88M |
| Accumulated Depreciation & Depletion | 18.86M | 16.87M | 17.95M | 17.79M |
| Property, Plant & Equipment, Net | 3.27M | 4.70M | 7.18M | 10.09M |
| Intangibles | 0.00 | 8.71M | 9.84M | 11.07M |
| Other Non-Current Assets | 9.80M | 3.80M | 3.37M | 3.91M |
| Total Non-Current Assets | 13.07M | 17.21M | 20.39M | 25.07M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 250.86M | 141.04M | 69.88M | 76.65M |
| Accounts Payable | 5.77M | 2.89M | 2.56M | 1.94M |
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Liabilities | 868.00K | 261.00K | 305.00K | 444.00K |
| Total Current Liabilities | 15.93M | 50.52M | 19.99M | 18.34M |
| Long Term Debt | 0.00 | 0.00 | 0.00 | 13.59M |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 15.77M | 39.29M | 80.99M | 50.17M |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 15.77M | 39.29M | 80.99M | 63.76M |
| Total Liabilities | 31.70M | 89.82M | 100.98M | 82.10M |
| Preferred Stock Equity | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Stock Equity | 219.16M | 51.22M | -31.10M | -5.45M |
| Common Par | 134.00K | 107.00K | 73.00K | 66.00K |
| Additional Paid In Capital | 926.67M | 726.47M | 591.88M | 555.69M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -708.12M | -675.72M | -623.74M | -562.18M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 470.00K | 365.00K | 683.00K | 970.00K |
| Total Capitalization | 219.16M | 51.22M | -31.10M | 8.14M |
| Total Equity | 219.16M | 51.22M | -31.10M | -5.45M |
| Total Liabilities & Stock Equity | 250.86M | 141.04M | 69.88M | 76.65M |
| Total Common Shares Outstanding | 133.96M | 107.22M | 73.09M | 66.37M |
| Preferred Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 118.76M | 90.83M | 70.72M | 61.50M |
| Diluted Weighted Shares Outstanding | 118.76M | 90.83M | 70.72M | 61.50M |
| Number of Employees | 107 | 105 | 109 | 144 |
| Number of Part-Time Employees | 0 | 0 | 0 | 0 |
Portfolios with IDIX
- Portfolio NameUser Type
- ProSeth Klarman - Baupost Group
- ContributorBreakout Stocks Of The Week...
- ContributorBreakout Stocks Of The Week...
- ContributorMost-Active Stocks for the ...
- ContributorStocks Under-$10 Moving Hig...
- Userdonnieny7 Portfolio 1 Specu...
- ContributorStocks Rising On Unusual Vo...
- Usernew
- UserLong Term Stock Picks
- ContributorStocks Under-$10 Setting Up...
Latest IDIX Headlines from TheStreet
- Idenix Announces Data Presentation At The 48th Annual Meeting Of The European Association For The Study Of The Liver (EASL) 04.08.13 | 04:04 pm
- Idenix Loses First Phase Of Patent Dispute With Gilead Sciences 03.25.13 | 07:03 am
- Stock Futures Rise as Cyprus Deal Is Clinched 03.25.13 | 06:03 am
- Idenix Pharmaceuticals Announces Decision By The United States Patent And Trademark Office Patent Trial And Appeal Board In The First Phase Of The Interference 03.22.13 | 04:03 pm
- Idenix Pharmaceuticals To Present At Two Upcoming Investor Conferences 02.26.13 | 04:02 pm
- Idenix Pharmaceuticals Reports Fourth Quarter And Year Ended 2012 Financial Results 02.25.13 | 04:02 pm
- Fisking Ray Dirks on Medgenics and Shaming Seeking Alpha 02.11.13 | 09:02 pm
- Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics 02.08.13 | 06:02 am
- Idenix Pharmaceuticals To Present At Two Upcoming Investor Conferences 02.05.13 | 04:02 pm
- Idenix Pharmaceuticals Provides Update On IDX184 And IDX19368 Development Programs 02.04.13 | 04:02 pm
Press Releases for IDIX
- Idenix Pharmaceuticals Announces Declaration Of A Patent Interference By The USPTO - PR Newswire 03.06.12 | 08:03 am
- Idenix Pharmaceuticals Elects Thomas Hodgson As Chairman Of The Board And Appoints Michael Wyzga To Its Board Of Directors - PR Newswire 03.01.12 | 04:03 pm
- Idenix Pharmaceuticals To Present At Three Upcoming Investor Conferences - PR Newswire 02.29.12 | 04:02 pm
- Idenix Pharmaceuticals To Present At The Citi Global Healthcare Conference - PR Newswire 02.21.12 | 04:02 pm
- Idenix To Host Conference Call Discussing Fourth Quarter And Year End 2011 Financial Results And Pipeline Update - PR Newswire 02.16.12 | 08:02 am
- Idenix Pharmaceuticals To Present At Two Upcoming Investor Conferences - PR Newswire 02.07.12 | 04:02 pm
- BioMed Realty Trust To Acquire Cambridge Place For $119 Million - PR Newswire 02.06.12 | 05:02 pm
- Idenix Announces Removal Of The Partial Clinical Hold On HCV Nucleotide Inhibitor, IDX184 - PR Newswire 02.03.12 | 08:02 am
- Idenix Reports Advancement Of HCV Development Pipeline - PR Newswire 01.09.12 | 07:01 am
- Idenix Reports Positive Interim Data For HCV Nucleotide Inhibitor, IDX184 - PR Newswire 01.09.12 | 07:01 am
Partner Headlines for IDIX
- Idenix Pharma Initiates Phase II Study - Analyst Blog - Zacks 05.31.13 | 11:05 pm
- DFC Global Lowers Outlook and 2 Other Stocks At 52-Week Lows - Wall St. Cheat Sheet 04.02.13 | 09:04 am
- Biotech Weekly Recap: Loads Of Bullishness, 2 Giant Rallies, And Selling - Seeking Alpha 12.02.12 | 09:12 am
- RIM, Green Mountain and Other Top Performing Nasdaq Stocks in November - Benzinga 12.01.12 | 01:12 pm
- New Second Generation Combination Therapy For HCV - First Or Best In The Market - Part 3 - Seeking Alpha 11.30.12 | 08:11 am
- UPDATE: Deutsche Bank Initiates Coverage on Idenix Pharmaceuticals with Buy Rating, $7 PT - Benzinga 11.28.12 | 09:11 am
- Morning Market Losers - Benzinga 09.19.12 | 09:09 am
- Idenix's Candidate on Clinical Hold - Analyst Blog - NASDAQ 08.30.12 | 10:08 pm
- Bad News for Bristol-Myers - Analyst Blog - NASDAQ 08.27.12 | 10:08 pm
- Bad News for Bristol-Myers - Analyst Blog - Zacks 08.27.12 | 06:08 pm
